Eton Pharmaceuticals, Inc. ETON
61.36 USD -0.63 (-1.02%)
Regular-session close
61.20 -0.16 -0.26%
Pre-market · Nov 20, 5:15 AM ET
61.07 Day range 63.38
14.27 52-week range 70.64
- YTD
- +262.86%
- 1 year
- +264.80%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 80.78M | 39.28M | 32.64M | 22.89M | 23.33M | |
| 43.56M | 23.68M | 22.06M | 15.96M | 20.50M | |
| -19.00K | -2.33M | -192.00K | -6.62M | 5.00K | |
| -4.60M | -3.82M | -936.00K | -9.02M | -1.96M | |
| -0.17 | -0.15 | -0.04 | -0.36 | -0.08 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 25.94M | 14.94M | 21.39M | 16.30M | 14.41M | |
| 92.11M | 76.12M | 31.74M | 25.03M | 27.46M | |
| 65.96M | 51.70M | 16.26M | 11.95M | 9.84M | |
| 31.02M | 29.92M | 5.40M | 6.52M | 6.70M | |
| 26.15M | 24.43M | 15.48M | 13.08M | 17.63M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.52M | 969.00K | 6.82M | 4.82M | -4.72M | |
| -333.00K | -40.01M | -775.00K | -2.79M | -2.56M | |
| 815.00K | 32.59M | -957.00K | -134.00K | 391.00K | |
| -333.00K | -26.00K | 0 | -38.00K | 691.00K | |
| 11.01M | -6.45M | 5.08M | 1.90M | -6.89M |
